NJR · Class I · 21 CFR 866.3740

FDA Product Code NJR: Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test

A Nucleic Acid Amplification Assay System (including Probes, Other Reagents, And Instrumentation) Is An Aid In The Identification Of Group B Streptococci From Pre-partum And Intra-partum Women To Establish Colonization Status.

Leading manufacturers include Cepheid.

2
Total
2
Cleared
463d
Avg days
2022
Since

List of Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test devices cleared through 510(k)

2 devices
1–2 of 2

How to use this database

This page lists all FDA 510(k) submissions for Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test devices (product code NJR). Click any device to view full submission details, including the decision date, manufacturer information, predicate device, and a link to the official FDA record.

These devices fall under the Microbiology FDA review panel. Browse all Microbiology devices →